Sons of statin: How the new arrivals narrowly missed disaster

8 by / on 1 Dec 2014, / in evidence based medicine, vitamins

Last month two new cholesterol lowering drugs stepped into the limelight at AHA’s (American Heart Association) annual conference. Neither is likely to make it to market until the end of next year but soon after that they are likely to be coming to a doctor’s surgery near you.